10 NGX Stocks That Stood Out in the First 6 Months of 2025

Despite a slowdown in overall market momentum, with the NGX All-Share Index posting a year-to-date return of 16.57% compared to 33.81% in the same period last year, individual stocks still found room to shine.

From impressive earnings rebounds to speculative buzz around penny stocks, the first half of 2025 showed that sharp rallies don’t always require a booming market. 

Investors rewarded companies with strong financials, improved outlooks, or simply the right mix of sentiment and timing. Here’s a closer look at the stocks that led the NGX performance charts in the first six months of 2025.

Beta Glass — +415%

Beta Glass emerged as the NGX’s best-performing stock in H1 2025, with its share price jumping over 400% to close at ₦334.

Its explosive run was backed by strong financials. The company reported a 639% surge in Q1 2025 pre-tax profit to ₦15.2 billion. This followed an already impressive FY 2024 result, with pre-tax profit up 123% to ₦21 billion.

Valuation-wise, the stock still looks reasonable with a price-to-earnings (P/E) ratio of 9.03x and price-to-book (P/B) of 2.68x. With its fundamentals intact and momentum on its side, Beta Glass is a mix of value and growth, and the market took notice.

Honeywell Flour Mills — +241%

From trading at ₦6.75 in January, the stock surged to ₦21.50 by the end of June. What sparked this confidence? A financial recovery. The company flipped from a ₦8.83 billion loss in the previous year to a ₦12.28 billion pre-tax profit within the first nine months of 2025.

Despite its rally, Honeywell still trades at relatively fair multiples: a P/E of 11.68x and a low price-to-sales (P/S) ratio of 0.38x. With improved investor confidence and room to grow, Honeywell is now firmly back on the radar.

The Initiates Plc (TIP) — +230%

Environmental services firm TIP delivered a 230% return, climbing from ₦2.50 to ₦8.25 in six months. The rally gained steam in May and June following impressive earnings.

TIP’s Q1 2025 pre-tax profit jumped 385% to ₦467 million, while revenue climbed 152% to ₦4.6 billion. Its declared ₦0.10 dividend also added to investor interest.

Unlike speculative penny stocks, TIP’s rise was anchored on fundamentals offering a rare blend of sector relevance and financial strength.

Vitafoam — +222%

Vitafoam shares surged 222%, making it one of the most consistent gainers of the year so far. Starting the year at ₦23.30, it hit ₦74.00 by June, fueled by solid Q1 results and sustained buying interest.

The company posted ₦4.4 billion in pre-tax profit in Q1 2025, reinforcing investor confidence. With a modest P/E of 7.04x and P/S of 0.93, Vitafoam still appears reasonably priced considering its steady fundamentals.

Its low beta of 0.41 suggests it’s a relatively safe stock, even in a volatile market.

Smart Products Nigeria — +200%

Smart Products proved that sometimes sentiment alone can drive a stock. Starting from a micro price of ₦0.20, it closed the half-year at ₦0.60, delivering a 200% gain.

Though tiny in market cap (₦27 million), the company caught attention with speculative flows and an eye-popping 40% dividend yield. It remains undervalued based on its P/B of 0.22 and P/S of 0.55.

However, its rally comes with high risk due to low liquidity and unclear fundamentals, making it more of a high-stakes bet than a long-term investment.

Neimeth Pharmaceuticals — +185%

Neimeth Pharmaceuticals had a breakout half-year, posting a 185% gain most of it happening in June when the stock soared by over 100% in a single month.

The key trigger? Shareholders approved a massive ₦20 billion capital raise at the company’s Annual General Meeting. That move signaled an ambitious expansion plan, which excited investors and ignited bullish sentiment.

While its earnings-based valuation (P/E of 2.35x) makes it look cheap, its high price-to-book and price-to-sales ratios suggest the market is already baking in future growth. It’s a classic case of buying into potential—at a premium.

Fidson Healthcare — +183.87%

Fidson nearly tripled in value over six months, closing June at ₦44.00 after starting the year at ₦15.75. Much of that momentum came in Q2, especially after the company reported blockbuster Q1 results.

Revenues surged by over 85% while pre-tax profit climbed a staggering 213%, showing that Fidson’s growth wasn’t just hype, it was real, and backed by earnings.

Even after the rally, the stock’s fundamentals remain solid. Its P/E of 12.62x and low volatility (beta 0.60) make it attractive to investors looking for a mix of growth and stability in the fast-evolving Nigerian healthcare space.

Presco Plc — +168%

Presco, one of Nigeria’s key players in the palm oil and agro-industrial space, delivered a 168% return in the first half of 2025. The share price climbed steadily, closing at ₦1,275 by the end of June more than double its January level.

The company’s performance was anchored by solid fundamentals. A strong Q1 showing with pre-tax profit nearing ₦59 billion, helped fuel investor interest.

While Presco isn’t cheap by book or revenue metrics, its consistent earnings, strong market position, and sector tailwinds in agriculture give it a sturdy investment case for long-term believers in the food and agro value chain.

Champion Breweries — +162%

Champion Breweries made a quiet but powerful entrance into the top performers list, rising 162% in six months. The share price rally intensified in May and June following impressive quarterly numbers.

Its Q1 pre-tax profit jumped by over 300%, sparking optimism that the company is finally turning the corner after years of mixed performance.

Despite its low volatility, the stock now trades at a high premium relative to earnings and revenue signaling strong investor faith in future potential or perhaps even interest in acquisition possibilities. However, with high expectations comes the risk of disappointment.

SCOA Nigeria — +161.65%

SCOA rounds off the list, growing 161.65% in just six months. The stock had its biggest surge in January, when it nearly doubled, and maintained momentum through the rest of H1.

SCOA’s valuation story is unusual, it trades at a high P/E of 22.5x but a low price-to-sales ratio of 0.5. That combination hints at investor enthusiasm for the company’s long-term prospects, possibly based more on sentiment than current performance.

Its negative beta suggests the stock doesn’t follow broader market movements, making it an unpredictable but potentially rewarding play—ideal for high-risk investors looking for big payoffs.